RankingsPricing
  1. US-listed companies
  2. RESMED INC
  3. Financials
  4. Net income margin (%)

RESMED INCRMD

Market cap
$36.7B
P/E ratio
SummaryFinancials
Period EndNet income margin (%) YoY (%)
Jun 30, 202527.2+24.91%
Jun 30, 202421.8+2.52%
Jun 30, 202321.3-2.43%
Jun 30, 202221.8+46.76%
Jun 30, 202114.8-29.40%
Jun 30, 202021+35.44%
Jun 30, 201915.5+15.10%
Jun 30, 201813.5-18.57%
Jun 30, 201716.6-13.59%
Jun 30, 201619.2-8.81%
Jun 30, 201521-5.34%
Jun 30, 201422.2+9.49%
Jun 30, 201320.3+8.90%
Jun 30, 201218.6+1.99%
Jun 30, 201118.3

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)